KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Shares Outstanding (Weighted Average) (2016 - 2025)

Vertex Pharmaceuticals has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $255.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $255.7 million for Q4 2025, down 0.85% from a year ago — trailing twelve months through Dec 2025 was $255.7 million (down 0.85% YoY), and the annual figure for FY2025 was $255.7 million, down 0.85%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $255.7 million at Vertex Pharmaceuticals, roughly flat from $255.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for VRTX hit a ceiling of $259.4 million in Q1 2021 and a floor of $255.1 million in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $257.6 million (2021), compared with a mean of $257.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 1.66% in 2022 and later increased 0.9% in 2023.
  • Vertex Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $257.7 million in 2021, then fell by 0.62% to $256.1 million in 2022, then grew by 0.62% to $257.7 million in 2023, then increased by 0.08% to $257.9 million in 2024, then fell by 0.85% to $255.7 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $255.7 million (Q4 2025), $255.6 million (Q3 2025), and $256.7 million (Q2 2025) per Business Quant data.